2C-B
Encyclopedia : 2 : 2C : 2CB : 2C-B
| 2C-B | |
|---|---|
| Chemical name | 4-Bromo-2,5-dimethoxy-phenethylamine or 2-(4-bromo-2,5-dimethoxyphenyl)-1-aminoethane |
| Chemical formula | C10H14BrNO2 |
| Molecular mass | 260.13 g/mol |
| Melting point |
237 - 239 °C decomposition (hydrochloride) 215 °C (hydrobromide) 208 - 209 °C (acetate) |
| CAS number | 66142-81-2 |
| SMILES | NCCC1=C(OC)C=C(Br)C(OC)=C1 |
 | |
2C-B is a lesser known psychedelic drug that was first synthesized by Alexander Shulgin in 1974. The chemical is 4-bromo-2,5-dimethoxyphenethylamine. In his book PIHKAL (Phenethylamines I Have Known and Loved), Shulgin lists the dosage range as 16–24 mg. 2C-B is a white powder sometimes found in pressed tablets or gel caps and is almost always taken orally or intranasally.
Origins and history
2C-B was synthesized from 2-5-dimethoxybenzaldehyde by Alexander Shulgin in 1974. On December 20, 1994, in a notice of proposed rulemaking published in the Federal Register (59 FR 65521) and after a review of relevant data, the Deputy Administrator of the Drug Enforcement Administration (DEA) proposed to place 4-bromo-2,5-DMPEA into Schedule I, making 2C-B illegal in the United States. This became permanent law July 2, 1995. Prior to this, 2C-B was commercially available as an aphrodisiac under the tradename "Eros" which was manufactured by the German phamaceutical company Drittewelle. Recently 2C-B has been distributed under the street name "Nexus." In the past 2C-B has also been distributed as "Eve", "Venus", "Bees", and (incorrectly) "bromo-mescaline." Internationally, 2C-B is a Schedule II drug under the Convention on Psychotropic Substances[link].
Toxicity
Not much information is known about the toxicity of 2C-B. Because 2C-B lacks an alpha-methyl group it isn't considered an amphetamine such as MDMA or methamphetamine. 2C-B does not seem to deplete the brain of serotonin, and this suggests that it may not share the neurotoxic characteristics of most amphetamines.There are no known deaths caused by 2C-B, however it is a drug that has been used thousands of times by a broad cross-section of the populace. Few (if any) certifiable studies have been conducted on 2C-B, so its physiological and psychological characteristics are relatively unknown.
Dosage
At minor oral doses (such as 2–5 mg,) 2C-B produces an entactogenic effect, but at common recreational doses (ranging from 10–25 mg) the drug can produce intense visual and auditory effects, a thorough evaluation of the effects is farther down in the article. It is very rare that 2C-B is insufflated. [link]By default, great care should be taken if one is recreationally experimenting with hallucinogens such as 2C-B or LSD. Notably, science has proven that many psychedelic drugs have some effect on the behavior of the mind, and such drugs may not interact well with users who have moderate-serious psychological disorders, such as schizophrenia or clinical depression.
Effects of 2C-B
The consumption of 2C-B produces the following effects.[link] Common recreational dosage is 10-25 mg.[link] As dosage increases, so does the intensity of the effects. (*)-Highly dosage dependent.- Open Eye Visuals (OEVs), such as cartoonistic distortions; red or green halos around objects.*
- Closed Eye Visuals (CEVs); more present than OEVs.*
- Has large effect on the body; tendency to bring out body imperfections to the user.
- Some recreational users report mild diarrhea; gas; nausea; and rarest of all, vomiting.
- Users describe effects as a mix between LSD and Ecstacy, although nothing like a combination of the two; much less dissociative and controlling then LSD; Far less directive than MDMA (Ecstacy).
- Mild stimulative effect; Positive mood shift; both very mild compared to LSD or MDMA.
- Much lighter on the body compared to MDMA; a less prominent comedown.
- Some users report an aphrodisiac-like effect of the drug;Though the body distortional effects are a 'turn-off.'
- Strongly effects ability to verbally communicate; some users find it easy, some difficult, to express their ideas verbally.
- Some report the creation of an inability or lack of desire to engage in complex thought.*
- Inappropriate giggling or smiling is common.
- Users describe process of reaching plateau as frigid or cold.*
- As dose increases, likewise do the chances of experiencing frightening or fearful effects.*
- Strong effects—similar to many entheogens—on attention span, such as engaging in deep thought on something random in surroundings.*
- Decline of visual accuity.
- Coordination is effected, some users lose balance or have perceptual distinction problems.*
- At low doses, an erratic process of reciprocating from very engaged in experience to strangely sober, and vice-versa; at times unexpected.
- Experienced users report the ability to take control of the above effect and reciprocate as they desire.
See also
External links
- [2C-B Entry in PIHKAL]
- [Erowid 2C-B vault] - includes reports from users of 2C-B, as well as scientific and government reports
- [2C-B Dosage chart]
- [2C-B history]
Categorization
| Psychedelic phenethylamines [http://encycl.opentopia.com/ edit] |
|---|
|
From Wikipedia, the Free Encyclopedia. Original article here. Support Wikipedia by contributing or donating.
All text is available under the terms of the GNU Free Documentation License See Wikipedia Copyrights for details.